Researchers and private companies are refining the technology for analyzing DNA and building curated databases that will provide a reliable reference for understanding the connections between rare mutations and disease. Research by Robert C. Green, associate professor of medicine at Brigham and Women’s Hospital; Heidi Rehm, associate professor of pathology at Brigham and Women’s Hospital; and David Altshuler, professor of genetics at Massachusetts General Hospital, is cited.
